These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 12656304)
21. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation. Lam YH; Tang MH; Lee CP; Tse HY Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400 [TBL] [Abstract][Full Text] [Related]
22. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening. Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371 [TBL] [Abstract][Full Text] [Related]
23. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan. Cicero S; Rembouskos G; Vandecruys H; Hogg M; Nicolaides KH Ultrasound Obstet Gynecol; 2004 Mar; 23(3):218-23. PubMed ID: 15027007 [TBL] [Abstract][Full Text] [Related]
24. Frontonasal facial angle in chromosomally normal fetuses at 11+0 to 13+6 weeks. Vicario R; Pirollo LM; De Angelis C; Narcisi M; Pietropolli A; Piccione E J Obstet Gynaecol Res; 2010 Dec; 36(6):1179-84. PubMed ID: 21040200 [TBL] [Abstract][Full Text] [Related]
25. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death. Spencer K; Cowans NJ; Avgidou K; Nicolaides KH Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214 [TBL] [Abstract][Full Text] [Related]
26. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509 [TBL] [Abstract][Full Text] [Related]
27. First-trimester Down's syndrome screening by fetal nuchal translucency measurement in Taiwan. Jou HJ; Shih JC; Wu SC; Li TC; Tzeng CY; Hsieh FJ J Formos Med Assoc; 2001 Apr; 100(4):257-61. PubMed ID: 11393125 [TBL] [Abstract][Full Text] [Related]
28. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects. Cicero S; Longo D; Rembouskos G; Sacchini C; Nicolaides KH Ultrasound Obstet Gynecol; 2003 Jul; 22(1):31-5. PubMed ID: 12858299 [TBL] [Abstract][Full Text] [Related]
29. Distribution of nuchal translucency thickness at 11 to 14 weeks of gestation in a normal Turkish population. Dinç G; Eyüboğlu İ Turk J Med Sci; 2021 Feb; 51(1):90-94. PubMed ID: 32777901 [TBL] [Abstract][Full Text] [Related]
30. Liver volume in trisomy 21 and euploid fetuses at 11 to 13 weeks. Gielchinsky Y; Zvanca M; Minekawa R; Persico N; Nicolaides KH Prenat Diagn; 2011 Jan; 31(1):28-32. PubMed ID: 21190270 [TBL] [Abstract][Full Text] [Related]
31. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. Spencer K; Nicolaides KH BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267 [TBL] [Abstract][Full Text] [Related]
33. [Frontomaxillary facial angle measurement at 11+0 to 13+6 weeks' gestation. Application in every day prenatal diagnosis of trisomy 21]. Cnota W; Borowski D; Włoch A; Wegrzyn P; Wielgoś M; Wójtowicz D; Sodowski K; Czuba B Ginekol Pol; 2013 Jul; 84(7):624-9. PubMed ID: 24032275 [TBL] [Abstract][Full Text] [Related]
34. First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population. Brizot ML; Carvalho MH; Liao AW; Reis NS; Armbruster-Moraes E; Zugaib M Ultrasound Obstet Gynecol; 2001 Dec; 18(6):652-5. PubMed ID: 11844209 [TBL] [Abstract][Full Text] [Related]
35. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population. Chasen ST; Sharma G; Kalish RB; Chervenak FA Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508 [TBL] [Abstract][Full Text] [Related]
36. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation. Snijders RJ; Sebire NJ; Nayar R; Souka A; Nicolaides KH Am J Med Genet; 1999 Sep; 86(3):205-7. PubMed ID: 10482866 [TBL] [Abstract][Full Text] [Related]
37. Comparison of likelihood ratios of first-trimester nuchal translucency measurements: multiples of median, delta or mixture. Sahota DS; Leung TY; Chen M; Chan LW; Fung TY; Lau TK Ultrasound Obstet Gynecol; 2010 Jul; 36(1):15-9. PubMed ID: 20503228 [TBL] [Abstract][Full Text] [Related]
38. Establishment and application of a normal range for nuchal translucency across the first trimester. Scott F; Boogert A; Sinosich M; Anderson J Prenat Diagn; 1996 Jul; 16(7):629-34. PubMed ID: 8843472 [TBL] [Abstract][Full Text] [Related]
39. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women. Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age. Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]